4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes

Eva M.M. Strijbis*, Jenny A. Nij Bijvank, Joep Killestein

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalMultiple Sclerosis Journal
DOIs
Publication statusAccepted/In press - 1 Jan 2020

Cite this